Safety of extended use of the weekly oral docetaxel formulation ModraDoc006/r in patients with advanced solid tumours
Phase of Trial: Phase II
Latest Information Update: 07 Aug 2018
At a glance
- Drugs Docetaxel (Primary) ; Ritonavir
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors Modra Pharmaceuticals
- 02 Aug 2018 Status changed from recruiting to completed.
- 12 May 2017 Status changed from not yet recruiting to recruiting.
- 28 Apr 2017 New trial record